Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02BXS
|
||||
| Former ID |
DNC011036
|
||||
| Drug Name |
4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diamine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [531085] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C18H17N3
|
||||
| Canonical SMILES |
C1=CC(=CC=C1CC2=CC=NC=C2)C3=CC(=C(C=C3)N)N
|
||||
| InChI |
1S/C18H17N3/c19-17-6-5-16(12-18(17)20)15-3-1-13(2-4-15)11-14-7-9-21-10-8-14/h1-10,12H,11,19-20H2
|
||||
| InChIKey |
SRXFPSNWVWAMBL-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [531085] | |
| 17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [531085] | ||
| PathWhiz Pathway | SteroidogenesisPW000045:Androgen and Estrogen Metabolism | ||||
| Steroidogenesis | |||||
| WikiPathways | Metapathway biotransformation | ||||
| Oxidation by Cytochrome P450 | |||||
| Metabolism of steroid hormones and vitamin D | |||||
| Corticotropin-releasing hormoneWP702:Metapathway biotransformation | |||||
| Steroid Biosynthesis | |||||
| Glucocorticoid & Mineralcorticoid Metabolism | |||||
| Prostate Cancer | |||||
| Phase 1 - Functionalization of compounds | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.